Diversified Trust Co increased its position in The Procter & Gamble Company (NYSE:PG – Free Report) by 9.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 141,725 shares of the company’s stock after buying an additional 11,677 shares during the period. Procter & Gamble accounts for 0.6% of Diversified Trust Co’s portfolio, making the stock its 26th largest holding. Diversified Trust Co’s holdings in Procter & Gamble were worth $23,760,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in PG. Acorn Creek Capital LLC raised its stake in Procter & Gamble by 2.8% in the third quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock valued at $376,000 after purchasing an additional 59 shares in the last quarter. Patrick M Sweeney & Associates Inc. raised its position in shares of Procter & Gamble by 1.1% during the 3rd quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock valued at $963,000 after buying an additional 59 shares in the last quarter. Traveka Wealth LLC lifted its holdings in shares of Procter & Gamble by 1.7% during the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock worth $616,000 after acquiring an additional 60 shares during the last quarter. Allen Mooney & Barnes Investment Advisors LLC grew its position in Procter & Gamble by 0.7% in the third quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 8,699 shares of the company’s stock worth $1,507,000 after acquiring an additional 61 shares in the last quarter. Finally, Valued Wealth Advisors LLC increased its stake in Procter & Gamble by 11.2% in the third quarter. Valued Wealth Advisors LLC now owns 605 shares of the company’s stock valued at $105,000 after acquiring an additional 61 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.
Wall Street Analyst Weigh In
A number of research firms have recently issued reports on PG. JPMorgan Chase & Co. upped their price objective on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a report on Thursday, September 19th. Barclays cut shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target on the stock. in a research report on Monday, September 30th. Evercore ISI boosted their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a report on Monday, October 21st. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $164.00 target price on shares of Procter & Gamble in a report on Monday, October 21st. Finally, Morgan Stanley boosted their price target on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research note on Monday, October 21st. Eight investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $179.75.
Procter & Gamble Stock Performance
Shares of PG stock traded up $0.70 during trading hours on Tuesday, reaching $161.30. The company had a trading volume of 1,981,638 shares, compared to its average volume of 5,297,689. The firm has a market cap of $379.87 billion, a PE ratio of 27.81, a price-to-earnings-growth ratio of 3.70 and a beta of 0.45. The business has a fifty day moving average price of $170.03 and a 200-day moving average price of $169.80. The Procter & Gamble Company has a one year low of $146.28 and a one year high of $180.43. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75.
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. During the same quarter in the previous year, the company posted $1.83 earnings per share. Procter & Gamble’s revenue was down .6% compared to the same quarter last year. Sell-side analysts predict that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.
Insider Buying and Selling
In other Procter & Gamble news, CEO R. Alexandra Keith sold 1,992 shares of the company’s stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total value of $338,640.00. Following the completion of the transaction, the chief executive officer now directly owns 13,783 shares in the company, valued at $2,343,110. This represents a 12.63 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Balaji Purushothaman sold 12,800 shares of the company’s stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the transaction, the insider now directly owns 11,566 shares of the company’s stock, valued at $1,954,538.34. This represents a 52.53 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 75,439 shares of company stock valued at $13,317,460. 0.18% of the stock is owned by insiders.
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
See Also
- Five stocks we like better than Procter & Gamble
- Business Services Stocks Investing
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- Using the MarketBeat Dividend Tax Calculator
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- Insider Trades May Not Tell You What You Think
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.